Bacterial peritonitis secondary to peritoneal dialysis

  • María Fernanda Lynch Mejía Médico General, Universidad de Costa Rica, San José.
Keywords: Peritonitis; Peritoneal Dialysis; infectious complications

Abstract

Peritoneal dialysis is one of the main renal replacement therapies for end-stage renal disease. Infections represent the second leading cause of death and correspond to great morbidity in this group of patients. Peritonitis associated with peritoneal dialysis is a preventable disease, and it is also the main complication of this procedure. Most cases are secondary to Gram-positive bacteria skin colonizers; although the importance of Gram-negative bacteria cannot be underestimated. Diagnosis is based both on clinical and microbiological criteria. Treatment consists on at least a two-week period antibiotic scheme. This topic review allows health care providers, patients and caregivers to be informed about this usual complication in order to prevent it, diagnose it and initiate early treatment with the intention to minimize its morbidity, mortality and complications.

References

1. Jain, D., Haddad, D., Goel, N. (2019). Choice of dialysis modality prior to kidney transplantation: Does it matter? World J Nephrol, 8(1):1-10.

2. Chen, H., Tarng, D., Huang, L. (2019). Risk factors associated with outcomes of peritoneal dialysis in Taiwan. Medicine (Baltimore), 98(6):1-8.

3. Mehrotra, R., Devuyst, O., Davies, S., Johnson, D. (2016). The Current State of Peritoneal Dialysis. J Am Soc Nephrol, 27(11):3238-3252.

4. Saxena, R. (2014). Peritoneal Dialysis: Misperceptions and Reality. Am J Med Sci, 348(3):250-261.

5. Salzer, W. (2018) Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis, 11:173-186.

6. Bagdasarian, N., Heung, M., Malani, PN. (2012). Infectious Complications of Dialysis Access Devices. Infect Dis Clin N Am, 26:127–141.

7. Lan, P., Johnson, D., McDonald, S. et al. (2014). The Association between Peritoneal Dialysis Modality and Peritonitis. Clin J Am Soc Nephrol, 9: 1091–1097.

8. Hansson, J., Watnick, S. (2016). Update on pertioneal dialysis: Core curriculum. Am J Kidney Dis, 67(1):151-164

9. Li, P., Szeto, C., Piriano, B. et al. (2016). ISPD Peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int, 36:481–508.

10. Ballinger, A., Palmer, S., Wiggins, KJ. et al. (2014). Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev; 4:1-96.

11. Caja Costarricense de Seguro Social, Dirección de Farmacoepidemiología. (2014). Lista Oficial de Medicamentos (LOM) y Normativa. ISSN: 1659-3847. San José-Costa Rica. 2014. Disponible en: https://www.ccss.sa.cr/lom
Published
2020-11-16
How to Cite
Lynch Mejía, M. F. (2020). Bacterial peritonitis secondary to peritoneal dialysis. Medicina Legal De Costa Rica, 36(2). Retrieved from //www.binasss.sa.cr/ojssalud/index.php/mlcr/article/view/136